40
Participants
Start Date
July 31, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Ravulizumab
Participants will receive Ravulizumab.
RECRUITING
Clinical Trial Site, Bergamo
NOT_YET_RECRUITING
Clinical Trial Site, Bologna
NOT_YET_RECRUITING
Clinical Trial Site, Brescia
RECRUITING
Clinical Trial Site, Florence
NOT_YET_RECRUITING
Clinical Trial Site, Imperia
RECRUITING
Clinical Trial Site, Lecco
NOT_YET_RECRUITING
Clinical Trial Site, Messina
NOT_YET_RECRUITING
Clinical Trial Site, Milan
NOT_YET_RECRUITING
Clinical Trial Site, Napoli
NOT_YET_RECRUITING
Clinical Trial Site, Novara
NOT_YET_RECRUITING
Clinical Trial Site, Orbassano
NOT_YET_RECRUITING
Clinical Trial Site, Padua
NOT_YET_RECRUITING
Clinical Trial Site, Palermo
NOT_YET_RECRUITING
Clinical Trial Site, Parma
NOT_YET_RECRUITING
Clinical Trial Site, Pavia
NOT_YET_RECRUITING
Clinical Trial Site, Pisa
NOT_YET_RECRUITING
Clinical Trial Site, Roma
NOT_YET_RECRUITING
Clinical Trial Site, Salerno
NOT_YET_RECRUITING
Clinical Trial Site, Sassari
NOT_YET_RECRUITING
Clinical Trial Site, Torino
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY